COX-2 Inhibition in Allergic Asthma

NCT01002690 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Etoricoxib

Sponsor

Barbro Dahlen

Collaborators

[object Object]